Sodium Nitroprusside for Advanced Low-Output Heart Failure

This publication has 35 references indexed in Scilit:

• Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
  American Heart Journal, 2005
• Nitric Oxide Protects Against Pathological Ventricular Remodeling
  Circulation Research, 2004
• Relationship between heart failure treatment and development of worsening renal function among hospitalized patients11Guest Editor for this manuscript was Peter M. Okin, MD, New York Hosptial-Cornell Medical Center, New York, NY.
  American Heart Journal, 2004
• Clinical Use of Inotropic Therapy for Heart Failure: Looking Backward or Forward? Part I: Inotropic Infusions During Hospitalization
  Circulation, 2003
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.
  Journal of Clinical Investigation, 1996
• Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure
  The American Journal of Cardiology, 1991
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
  New England Journal of Medicine, 1986
• Systemic and coronary hemodynamic effects of sodium nitroprusside
  American Heart Journal, 1974
• Studies on the acute cardiovascular effects of intravenous sodium nitroprusside
  The American Journal of Cardiology, 1962